RAMM Pharma Corp. announced the appointment of José Roldan as interim-Chief Financial Officer of the Company, effective immediately. Mr. Roldan succeeds Mr. Guillermo Delmonte, who is currently on medical leave.
Mr. Roldan is a Public Accountant specializing in audits of financial and commercial institutions. He has extensive experience in the cannabis space coupled with knowledge of central bank regulations and International Financial Reporting Standards. Prior to joining RAMM, Mr. Roldan worked as a senior auditor with KPMG Uruguay for six years.
For more information:
RAMM Pharma 
www.rammpharma.com
Announcements
Vacancies
RAMM Pharma Corp. appoints new Interim-Chief Financial Officer
Publication date:
Receive the daily newsletter in your email for free | Click here
Other news in this sector:
- 2023-09-22 Erin DuPree tapped to oversee Minnesota’s cannabis industry
- 2023-09-20 IM Cannabis announces CFO departure
- 2023-09-20 US (MA): Cannabis Control Commission chair suspended
- 2023-09-12 Paul Pedersen departs from his role as Chief Executive Officer and President at Nextleaf
- 2023-09-05 Nikki Hargreaves new Branch Manager Royal Brinkman UK
- 2023-09-04 Chandra Panchal, PhD retires from board of directors of Avicanna
- 2023-08-23 Transition of leadership at Pure Sunfarms
- 2023-08-17 Gloria Govan named General Partner of cannabis real estate lender
- 2023-08-17 US (MA): Anand Shahi appointed CFO of Nova Farms
- 2023-08-09 Keith Adams steps down as CFO of 4Front
- 2023-08-08 INCBA welcomes the 2023-2025 Board of Directors
- 2023-08-07 Verano makes management changes
- 2023-07-14 Sabas Carrillo appointed as the CEO of Unrivaled Brands
- 2023-07-06 MedMen appoints CEO and CFO
- 2023-06-28 Würk appoints Jennifer Meadows as Chief Operating Officer
- 2023-06-20 Tim Mullany appointed as CFO of Trulieve
- 2023-06-08 Joerg Sommer appointed as President of One World Products
- 2023-06-08 Jonathan Hirsh joins Agra Ventures' Board of Directors
- 2023-06-05 Acreage announces leadership transition of CEO
- 2023-06-02 “The number of cannabis projects in Europe might have decreased, the quality has improved”
